Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$4,413,548
+$157,628 QoQ
Shares Held
28,162
+1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#286
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. NVS ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
This page
|
28,162 | $4,413,548 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,413,548 | 28,162 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $4,255,920 | 27,862 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,895,102 | 28,252 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,584,563 | 27,952 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,404,737 | 28,136 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,225,784 | 28,936 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,365,563 | 34,586 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,628,404 | 40,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,257,335 | 39,990 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,778,461 | 49,400 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,197,430 | 51,475 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,553,672 | 64,340 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $11,856,924 | 117,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,734,540 | 236,245 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $31,437,201 | 346,530 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $28,719,997 | 377,845 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $34,178,098 | 404,331 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $36,447,487 | 415,356 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $35,967,661 | 411,200 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $32,888,153 | 402,154 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,798,086 | 414,271 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $36,519,193 | 427,225 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $40,024,626 | 423,855 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $37,006,262 | 425,555 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $38,194,218 | 437,305 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $36,047,551 | 437,205 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||